[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":30095578.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":6753000.0,"Liabilities_0_Q2_USD":83288398.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":591842169.0,"LiabilitiesCurrent_0_Q2_USD":51748999.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":164344664.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-224808880.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-131326659.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":1994000.0,"NetIncomeLoss_1_Q2_USD":-82139958.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q2_USD":0.0,"NetIncomeLossAttributableToNoncontrollingInterest_2_Q2_USD":0.0,"OperatingExpenses_1_Q2_USD":83474759.0,"OperatingExpenses_2_Q2_USD":136400371.0,"OperatingIncomeLoss_1_Q2_USD":-83201935.0,"OperatingIncomeLoss_2_Q2_USD":-135756426.0,"OperatingLeaseLiability_0_Q2_USD":19261000.0,"NetIncomeLoss_2_Q2_USD":-136542089.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":2463878.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":4023000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":3063000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":55074.0,"IncreaseDecreaseInDerivativeLiabilities_2_Q2_USD":0.0,"IncreaseDecreaseInOtherAccruedLiabilities_2_Q2_USD":0.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":-24126582.0,"IncreaseDecreaseInOtherOperatingLiabilities_2_Q2_USD":6478.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":51944060.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":2879896.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":3001000.0,"InterestExpense_1_Q2_USD":466726.0,"InterestIncomeOperating_1_Q2_USD":928111.0,"InterestIncomeOperating_2_Q2_USD":1697347.0,"InterestPaidNet_2_Q2_USD":544315.0,"LeaseCost_1_Q2_USD":827000.0,"LeaseCost_2_Q2_USD":1700000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":26014000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":4045000.0,"InterestExpense_2_Q2_USD":979760.0,"IncreaseDecreaseInAccountsReceivableRelatedParties_2_Q2_USD":219159.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":16797476.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.085,"PropertyPlantAndEquipmentNet_0_Q2_USD":18111288.0,"ResearchAndDevelopmentExpense_1_Q2_USD":70808418.0,"ResearchAndDevelopmentExpense_2_Q2_USD":109852836.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1042738901.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":272824.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":643945.0,"ShareBasedCompensation_2_Q2_USD":15242305.0,"ProfitLoss_2_Q2_USD":-136542089.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q2_USD":5.25,"ShortTermInvestments_0_Q2_USD":384752382.0,"StockholdersEquity_0_Q2_USD":508553771.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":508553771.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":3441423.0,"UnrealizedGainLossOnInvestments_2_Q2_USD":-211000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":209561064.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":206007497.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":7.91,"OperatingLeaseRightOfUseAsset_0_Q2_USD":12173414.0,"ProfitLoss_1_Q2_USD":-82139958.0,"ProceedsFromSaleOfShortTermInvestments_2_Q2_USD":83466967.0,"OtherAssetsNoncurrent_0_Q2_USD":1830866.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":2478.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-11941.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-2679.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":2182.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":64141.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":185281.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":6154794.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":194259.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":418734.0,"PaymentsToAcquireShortTermInvestments_2_Q2_USD":307857113.0,"PreferredStockValue_0_Q2_USD":0.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":84592179.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":162105030.0,"ProceedsFromMinorityShareholders_2_Q2_USD":0.0,"ProceedsFromNotesPayable_2_Q2_USD":0.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":3915160.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-5431637.0,"IncreaseDecreaseInAccountsPayableRelatedParties_2_Q2_USD":1130877.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":8891770.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"CommonStockSharesAuthorized_0_Q2_shares":600000000.0,"CommonStockSharesIssued_0_Q2_shares":210146880.0,"CommonStockSharesOutstanding_0_Q2_shares":210146880.0,"CommonStockValue_0_Q2_USD":210146.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-82140159.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-136551848.0,"CashDivestedFromDeconsolidation_2_Q2_USD":0.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q2_USD":0.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":-82140159.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":-136551848.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":109128.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":71788.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q2_USD":35000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":39000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_0_Q2_position":4.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2_Q2_USD":0.0,"DebtSecuritiesAvailableForSaleRealizedGain_1_Q2_USD":358000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-191802816.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":443700000.0,"AccountsReceivableNetCurrent_0_Q2_USD":13128330.0,"AccountsReceivableRelatedPartiesCurrent_0_Q2_USD":722941.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-265909.0,"AdditionalPaidInCapital_0_Q2_USD":1551348435.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":5646358.0,"AmortizationOfIntangibleAssets_1_Q2_USD":130000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":266874.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":58925302.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":16563562.0,"AssetsCurrent_0_Q2_USD":542424625.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":1602498.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":633448.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":383783332.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":384752382.0,"Capital_0_Q2_USD":490700000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":58925302.0,"Assets_0_Q2_USD":591842169.0,"DebtSecuritiesAvailableForSaleRealizedGain_2_Q2_USD":358000.0,"DebtSecuritiesAvailableForSaleRealizedLoss_1_Q2_USD":194000.0,"DebtSecuritiesAvailableForSaleRealizedLoss_2_Q2_USD":204000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":254000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":253000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":253000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":276000.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":10473761.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":2879896.0,"ForeignCurrencyTransactionGainLossBeforeTax_2_Q2_USD":176927.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q2_USD":493000.0,"GainLossOnInvestments_2_Q2_USD":153252.0,"GeneralAndAdministrativeExpense_2_Q2_USD":26547535.0,"Goodwill_0_Q2_USD":10513371.0,"GoodwillGross_0_Q2_USD":10513371.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":-82139958.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":-136107702.0,"IncomeLossFromEquityMethodInvestments_1_Q2_USD":0.0,"IncomeLossFromEquityMethodInvestments_2_Q2_USD":-434387.0,"GeneralAndAdministrativeExpense_1_Q2_USD":12666341.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":7593865.0,"EquitySecuritiesFvNiUnrealizedLoss_2_Q2_USD":711465.0,"EquitySecuritiesFvNiUnrealizedGainLoss_2_Q2_USD":-711465.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_0_Q2_position":22.0,"DeconsolidationGainOrLossAmount_1_Q2_USD":0.0,"DeconsolidationGainOrLossAmount_2_Q2_USD":0.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":32046.0,"Depreciation_2_Q2_USD":1361595.0,"DueToRelatedPartiesCurrent_0_Q2_USD":1773846.0,"EarningsPerShareBasic_1_Q2_USD":-0.39,"EarningsPerShareBasic_2_Q2_USD":-0.66,"EarningsPerShareDiluted_1_Q2_USD":-0.39,"EarningsPerShareDiluted_2_Q2_USD":-0.66,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-11941.0,"EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_1_Q2_USD":0.0,"EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_2_Q2_USD":0.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q2_USD":19800000.0,"EquityMethodInvestments_0_Q2_USD":0.0,"EquitySecuritiesFvNiCurrentAndNoncurrent_0_Q2_USD":3908709.0,"EquitySecuritiesFvNiUnrealizedGainLoss_1_Q2_USD":136493.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":209561064.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":206007497.0,"Ticker":"INO","CIK":"1055726","name":"INOVIO PHARMACEUTICALS, INC.","OfficialName":"Inovio Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"674206680.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20210809"}]